ElectroCore’s nVNS Shows Promise for Faster Pilot Training
ROCKAWAY, N.J. — electroCore, Inc. (NASDAQ: ECOR), a bioelectronic medicine company, recently shared research showing that its Transcutaneous Vagus Nerve Stimulation (nVNS) technology can help accelerate Air Force pilot training.
Insights from the Air Force Research Laboratories
In a recent presentation, Dr. Justin Estepp of the Air Force Research Laboratories (AFRL) outlined results from a study evaluating electroCore’s TAC-STIM device in a pilot-training context. The work, conducted at Wright-Patterson Air Force Base, enrolled 28 participants and split them into two groups: one received active nVNS, and the other received a sham treatment.
How the Study Was Run
Participants first completed baseline assessments. Over four consecutive days, they self-administered two-minute nVNS sessions both before and during training tasks. Each person then performed 12 glideslope simulator trials, each about 2.5 minutes long. The active nVNS group showed steady gains in sensorimotor performance—improving from 37% after the first trial to 51% by the final trials.
What the Numbers Say
Results favored the nVNS group with statistical significance (p < 0.05). A Bayesian analysis further indicated a 99% probability that active nVNS outperformed sham, pointing to faster learning rates among TAC-STIM users.
Why This Matters for Military Training
Dan Goldberger, electroCore’s CEO, noted the importance of these findings for training and mission readiness, underscoring the company’s focus on tools that support both cognitive and physical performance. It’s a practical step toward helping service members learn critical skills more efficiently.
TAC-STIM: A Portable Approach to Human Performance
TAC-STIM uses patented technology to stimulate the vagus nerve in a non-invasive, handheld format. It’s designed for quick use and quick effects, supporting areas such as memory retention and attention while also helping with mood and fatigue. The device is considered a low-risk option for general wellness. It isn’t intended to diagnose or treat medical conditions.
Looking Ahead for nVNS
ElectroCore continues to evaluate TAC-STIM across other studies and service branches. As evidence develops, the technology could influence training protocols and day-to-day operational effectiveness, shaping how military personnel build and maintain skills.
About electroCore, Inc.
ElectroCore develops bioelectronic medicine centered on nVNS. The company focuses on commercializing devices that support health management and general wellbeing, with efforts underway in both domestic and international markets. That commitment—practical tools, real-world use—remains core to the company’s mission.
Frequently Asked Questions
What is TAC-STIM, in plain terms?
TAC-STIM is a handheld, non-invasive device that stimulates the vagus nerve. It’s designed to support cognitive functions like attention and memory, and to help with mood and fatigue as part of general wellness.
How was the AFRL study structured?
Participants completed a baseline, then for four straight days used two-minute nVNS sessions before and during training. They ran 12 glideslope simulator trials (about 2.5 minutes each), allowing researchers to track performance over time.
What did the study find about performance gains?
The active nVNS group improved more than the sham group. Sensorimotor performance in the nVNS group rose from 37% after the first trial to 51% by the final trials, with statistical significance (p < 0.05) and a 99% Bayesian probability favoring active over sham.
What does this mean for Air Force pilot training?
The results suggest nVNS can speed up learning for key pilot tasks, potentially making training more efficient and effective without changing the training content itself.
Is TAC-STIM a medical treatment?
No. TAC-STIM is positioned as a low-risk option for general wellness. It’s not intended to diagnose or treat medical conditions.
